1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Deferiprone Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Deferiprone Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Deferiprone Drug by Country/Region, 2018, 2022 & 2029
2.2 Deferiprone Drug Segment by Type
2.2.1 Oral Solution
2.2.2 Tablet
2.2.3 Capsule
2.3 Deferiprone Drug Sales by Type
2.3.1 Global Deferiprone Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Deferiprone Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Deferiprone Drug Sale Price by Type (2018-2023)
2.4 Deferiprone Drug Segment by Application
2.4.1 Aldult
2.4.2 Child
2.5 Deferiprone Drug Sales by Application
2.5.1 Global Deferiprone Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Deferiprone Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Deferiprone Drug Sale Price by Application (2018-2023)
3 Global Deferiprone Drug by Company
3.1 Global Deferiprone Drug Breakdown Data by Company
3.1.1 Global Deferiprone Drug Annual Sales by Company (2018-2023)
3.1.2 Global Deferiprone Drug Sales Market Share by Company (2018-2023)
3.2 Global Deferiprone Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Deferiprone Drug Revenue by Company (2018-2023)
3.2.2 Global Deferiprone Drug Revenue Market Share by Company (2018-2023)
3.3 Global Deferiprone Drug Sale Price by Company
3.4 Key Manufacturers Deferiprone Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Deferiprone Drug Product Location Distribution
3.4.2 Players Deferiprone Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Deferiprone Drug by Geographic Region
4.1 World Historic Deferiprone Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Deferiprone Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Deferiprone Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Deferiprone Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Deferiprone Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Deferiprone Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Deferiprone Drug Sales Growth
4.4 APAC Deferiprone Drug Sales Growth
4.5 Europe Deferiprone Drug Sales Growth
4.6 Middle East & Africa Deferiprone Drug Sales Growth
5 Americas
5.1 Americas Deferiprone Drug Sales by Country
5.1.1 Americas Deferiprone Drug Sales by Country (2018-2023)
5.1.2 Americas Deferiprone Drug Revenue by Country (2018-2023)
5.2 Americas Deferiprone Drug Sales by Type
5.3 Americas Deferiprone Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Deferiprone Drug Sales by Region
6.1.1 APAC Deferiprone Drug Sales by Region (2018-2023)
6.1.2 APAC Deferiprone Drug Revenue by Region (2018-2023)
6.2 APAC Deferiprone Drug Sales by Type
6.3 APAC Deferiprone Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Deferiprone Drug by Country
7.1.1 Europe Deferiprone Drug Sales by Country (2018-2023)
7.1.2 Europe Deferiprone Drug Revenue by Country (2018-2023)
7.2 Europe Deferiprone Drug Sales by Type
7.3 Europe Deferiprone Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Deferiprone Drug by Country
8.1.1 Middle East & Africa Deferiprone Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Deferiprone Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Deferiprone Drug Sales by Type
8.3 Middle East & Africa Deferiprone Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Deferiprone Drug
10.3 Manufacturing Process Analysis of Deferiprone Drug
10.4 Industry Chain Structure of Deferiprone Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Deferiprone Drug Distributors
11.3 Deferiprone Drug Customer
12 World Forecast Review for Deferiprone Drug by Geographic Region
12.1 Global Deferiprone Drug Market Size Forecast by Region
12.1.1 Global Deferiprone Drug Forecast by Region (2024-2029)
12.1.2 Global Deferiprone Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Deferiprone Drug Forecast by Type
12.7 Global Deferiprone Drug Forecast by Application
13 Key Players Analysis
13.1 ApoPharma Inc
13.1.1 ApoPharma Inc Company Information
13.1.2 ApoPharma Inc Deferiprone Drug Product Portfolios and Specifications
13.1.3 ApoPharma Inc Deferiprone Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 ApoPharma Inc Main Business Overview
13.1.5 ApoPharma Inc Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Deferiprone Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Deferiprone Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral Solution
Table 4. Major Players of Tablet
Table 5. Major Players of Capsule
Table 6. Global Deferiprone Drug Sales by Type (2018-2023) & (K Units)
Table 7. Global Deferiprone Drug Sales Market Share by Type (2018-2023)
Table 8. Global Deferiprone Drug Revenue by Type (2018-2023) & ($ million)
Table 9. Global Deferiprone Drug Revenue Market Share by Type (2018-2023)
Table 10. Global Deferiprone Drug Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Deferiprone Drug Sales by Application (2018-2023) & (K Units)
Table 12. Global Deferiprone Drug Sales Market Share by Application (2018-2023)
Table 13. Global Deferiprone Drug Revenue by Application (2018-2023)
Table 14. Global Deferiprone Drug Revenue Market Share by Application (2018-2023)
Table 15. Global Deferiprone Drug Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Deferiprone Drug Sales by Company (2018-2023) & (K Units)
Table 17. Global Deferiprone Drug Sales Market Share by Company (2018-2023)
Table 18. Global Deferiprone Drug Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Deferiprone Drug Revenue Market Share by Company (2018-2023)
Table 20. Global Deferiprone Drug Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Deferiprone Drug Producing Area Distribution and Sales Area
Table 22. Players Deferiprone Drug Products Offered
Table 23. Deferiprone Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Deferiprone Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Deferiprone Drug Sales Market Share Geographic Region (2018-2023)
Table 28. Global Deferiprone Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Deferiprone Drug Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Deferiprone Drug Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Deferiprone Drug Sales Market Share by Country/Region (2018-2023)
Table 32. Global Deferiprone Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Deferiprone Drug Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Deferiprone Drug Sales by Country (2018-2023) & (K Units)
Table 35. Americas Deferiprone Drug Sales Market Share by Country (2018-2023)
Table 36. Americas Deferiprone Drug Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Deferiprone Drug Revenue Market Share by Country (2018-2023)
Table 38. Americas Deferiprone Drug Sales by Type (2018-2023) & (K Units)
Table 39. Americas Deferiprone Drug Sales by Application (2018-2023) & (K Units)
Table 40. APAC Deferiprone Drug Sales by Region (2018-2023) & (K Units)
Table 41. APAC Deferiprone Drug Sales Market Share by Region (2018-2023)
Table 42. APAC Deferiprone Drug Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Deferiprone Drug Revenue Market Share by Region (2018-2023)
Table 44. APAC Deferiprone Drug Sales by Type (2018-2023) & (K Units)
Table 45. APAC Deferiprone Drug Sales by Application (2018-2023) & (K Units)
Table 46. Europe Deferiprone Drug Sales by Country (2018-2023) & (K Units)
Table 47. Europe Deferiprone Drug Sales Market Share by Country (2018-2023)
Table 48. Europe Deferiprone Drug Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Deferiprone Drug Revenue Market Share by Country (2018-2023)
Table 50. Europe Deferiprone Drug Sales by Type (2018-2023) & (K Units)
Table 51. Europe Deferiprone Drug Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Deferiprone Drug Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Deferiprone Drug Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Deferiprone Drug Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Deferiprone Drug Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Deferiprone Drug Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Deferiprone Drug Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Deferiprone Drug
Table 59. Key Market Challenges & Risks of Deferiprone Drug
Table 60. Key Industry Trends of Deferiprone Drug
Table 61. Deferiprone Drug Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Deferiprone Drug Distributors List
Table 64. Deferiprone Drug Customer List
Table 65. Global Deferiprone Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Deferiprone Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Deferiprone Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Deferiprone Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Deferiprone Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Deferiprone Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Deferiprone Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Deferiprone Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Deferiprone Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Deferiprone Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Deferiprone Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Deferiprone Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Deferiprone Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Deferiprone Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. ApoPharma Inc Basic Information, Deferiprone Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. ApoPharma Inc Deferiprone Drug Product Portfolios and Specifications
Table 81. ApoPharma Inc Deferiprone Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. ApoPharma Inc Main Business
Table 83. ApoPharma Inc Latest Developments
Table 84. Chiesi Farmaceutici SpA Basic Information, Deferiprone Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Chiesi Farmaceutici SpA Deferiprone Drug Product Portfolios and Specifications
Table 86. Chiesi Farmaceutici SpA Deferiprone Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Chiesi Farmaceutici SpA Main Business
Table 88. Chiesi Farmaceutici SpA Latest Developments
List of Figures
Figure 1. Picture of Deferiprone Drug
Figure 2. Deferiprone Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Deferiprone Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Deferiprone Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Deferiprone Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral Solution
Figure 10. Product Picture of Tablet
Figure 11. Product Picture of Capsule
Figure 12. Global Deferiprone Drug Sales Market Share by Type in 2022
Figure 13. Global Deferiprone Drug Revenue Market Share by Type (2018-2023)
Figure 14. Deferiprone Drug Consumed in Aldult
Figure 15. Global Deferiprone Drug Market: Aldult (2018-2023) & (K Units)
Figure 16. Deferiprone Drug Consumed in Child
Figure 17. Global Deferiprone Drug Market: Child (2018-2023) & (K Units)
Figure 18. Global Deferiprone Drug Sales Market Share by Application (2022)
Figure 19. Global Deferiprone Drug Revenue Market Share by Application in 2022
Figure 20. Deferiprone Drug Sales Market by Company in 2022 (K Units)
Figure 21. Global Deferiprone Drug Sales Market Share by Company in 2022
Figure 22. Deferiprone Drug Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Deferiprone Drug Revenue Market Share by Company in 2022
Figure 24. Global Deferiprone Drug Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Deferiprone Drug Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Deferiprone Drug Sales 2018-2023 (K Units)
Figure 27. Americas Deferiprone Drug Revenue 2018-2023 ($ Millions)
Figure 28. APAC Deferiprone Drug Sales 2018-2023 (K Units)
Figure 29. APAC Deferiprone Drug Revenue 2018-2023 ($ Millions)
Figure 30. Europe Deferiprone Drug Sales 2018-2023 (K Units)
Figure 31. Europe Deferiprone Drug Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Deferiprone Drug Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Deferiprone Drug Revenue 2018-2023 ($ Millions)
Figure 34. Americas Deferiprone Drug Sales Market Share by Country in 2022
Figure 35. Americas Deferiprone Drug Revenue Market Share by Country in 2022
Figure 36. Americas Deferiprone Drug Sales Market Share by Type (2018-2023)
Figure 37. Americas Deferiprone Drug Sales Market Share by Application (2018-2023)
Figure 38. United States Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Deferiprone Drug Sales Market Share by Region in 2022
Figure 43. APAC Deferiprone Drug Revenue Market Share by Regions in 2022
Figure 44. APAC Deferiprone Drug Sales Market Share by Type (2018-2023)
Figure 45. APAC Deferiprone Drug Sales Market Share by Application (2018-2023)
Figure 46. China Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Deferiprone Drug Sales Market Share by Country in 2022
Figure 54. Europe Deferiprone Drug Revenue Market Share by Country in 2022
Figure 55. Europe Deferiprone Drug Sales Market Share by Type (2018-2023)
Figure 56. Europe Deferiprone Drug Sales Market Share by Application (2018-2023)
Figure 57. Germany Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Deferiprone Drug Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Deferiprone Drug Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Deferiprone Drug Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Deferiprone Drug Sales Market Share by Application (2018-2023)
Figure 66. Egypt Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Deferiprone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Deferiprone Drug in 2022
Figure 72. Manufacturing Process Analysis of Deferiprone Drug
Figure 73. Industry Chain Structure of Deferiprone Drug
Figure 74. Channels of Distribution
Figure 75. Global Deferiprone Drug Sales Market Forecast by Region (2024-2029)
Figure 76. Global Deferiprone Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Deferiprone Drug Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Deferiprone Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Deferiprone Drug Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Deferiprone Drug Revenue Market Share Forecast by Application (2024-2029)

※参考情報 デフェプロン（Deferiprone）は、主に鉄過剰症を治療するために使用されるキレート剤の一種です。鉄過剰症は、血液疾患や遺伝性の鉄代謝異常など様々な理由で体内に蓄積された鉄が毒性を示す状態を指します。デフェプロンは、この過剰な鉄を体外に排出することによって、脳、心臓、肝臓などの臓器に対する鉄の毒性を軽減します。 デフェプロンは、その化学構造において特異な特徴を持っており、特に三つの官能基を介して鉄イオンと結合します。この結合が鉄を効率的にキレートする理由であり、結果として体内の鉄の蓄積を抑制することができます。また、デフェプロンは経口投与が可能であり、他の鉄キレート剤に比べて患者にとって服用が容易である点も大きな利点です。 デフェプロンは、主に二つの鉄過剰症の治療に用いられます。一つは、サラセミア（サラセミア症候群などの遺伝性の血液疾患）による慢性的な鉄過剰で、もう一つは、定期的な輸血によって引き起こされる鉄過剰（輸血関連鉄過剰症）です。このような疾患においては、頻繁に輸血を受けることで鉄が蓄積され、鉄過剰症を引き起こすため降鉄療法が必要とされます。 デフェプロンの投与は、患者の体内の鉄レベルを定期的にモニターすることにより、具体的な治療効果を評価します。血清フェリチン値やトランスフェリン飽和度といった指標がよく使用され、これに基づいて適切な投与量や投与間隔が調整されます。多くの場合、デフェプロンは他の治療法と組み合わせて使用されることが一般的です。 デフェプロンにはいくつかの副作用があります。最も一般的なものは、胃腸障害や、関節痛、皮疹などのアレルギー反応です。中でも、好中球減少症（白血球の一種である好中球が減少する状態）は、デフェプロンの使用中に注意が必要な副作用となります。このため、定期的な血液検査が推奨されており、好中球の数が低下した場合には、使用を中止するか、用量を調整することが求められます。 さらに、デフェプロンは鉄以外の金属イオンともキレートするため、長期間の使用において他のミネラルの吸収や代謝に影響を及ぼす可能性があり、それも副作用の一つとされています。したがって、患者は定期的に医師による診察を受け、必要に応じて血液検査やサプリメントの調整が行われます。 デフェプロンの関連技術としては、鉄過剰排出を効率的に行うための研究が進められています。例えば、ナノテクノロジーを用いた新しいキレート剤の開発や、デフェプロンの効果を向上させるための配合技術が注目されています。また、患者の服用 compliance を向上させるために、デフェプロンの持続放出型製剤の開発も行われています。これにより、薬剤の服用回数を減少させ、患者の負担軽減が期待されています。 さらに、医療の進展に伴い、精密医療の観点から個別化医療が重要視されています。患者一人ひとりの遺伝的背景や病態に応じたデフェプロンの最適化投与が求められるようになっています。このようなアプローチにより、効果的な鉄過剰症治療が実現することが期待されています。 デフェプロンは、鉄過剰症治療において重要な役割を果たす薬剤であり、その効果を最大限に引き出すための研究開発も盛んに行われています。将来的には、さらに安全性と効果を兼ね備えた新たな治療法が登場する可能性もあり、患者にとって益のある進展が期待されます。心血管系や内分泌系への影響など、さらなる研究が必要とされる分野も多く、今後の展望に注目が集まります。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer